(Q37323711)

19 August 2017

1 reference

title

Acute kidney injury in cirrhosis (English)

1 reference

19 August 2017

1 reference

2

Chirag R Parikh

1 reference

19 August 2017

author name string

Guadalupe Garcia-Tsao

series ordinal

1

1 reference

19 August 2017

Antonella Viola

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

48

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

2064-2077

1 reference

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

19 August 2017

cites work

1 reference

Model for end-stage liver disease (MELD) and allocation of donor livers

21 January 2018

1 reference

Prediction of survival after liver transplantation by pre-transplant parameters

21 January 2018

1 reference

Pathogenesis and treatment of hepatorenal syndrome

21 January 2018

1 reference

Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis

21 January 2018

1 reference

Diagnosis and treatment of acute renal failure in patients with cirrhosis

21 January 2018

1 reference

Acute renal dysfunction in liver diseases

21 January 2018

1 reference

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

Renal failure in the patient with cirrhosis. The role of active vasoconstriction.

21 January 2018

1 reference

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

21 January 2018

1 reference

The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule

21 January 2018

1 reference

Circulatory function and hepatorenal syndrome in cirrhosis.

21 January 2018

1 reference

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation

21 January 2018

1 reference

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

21 January 2018

1 reference

Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study

21 January 2018

1 reference

The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis

21 January 2018

1 reference

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

21 January 2018

1 reference

The cardiac output at rest in Laennec's cirrhosis

21 January 2018

1 reference

Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function

21 January 2018

1 reference

Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis

21 January 2018

1 reference

Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome

21 January 2018

1 reference

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

21 January 2018

1 reference

Molecular and structural consequences of early renal allograft injury

21 January 2018

1 reference

Extent of bilirubin interference with Beckman creatinine methods

21 January 2018

1 reference

Review article: renal function assessment in cirrhosis - difficulties and alternative measurements

21 January 2018

1 reference

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

21 January 2018

1 reference

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

21 January 2018

1 reference

Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study

21 January 2018

1 reference

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

21 January 2018

1 reference

Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial

21 January 2018

1 reference

Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study

21 January 2018

1 reference

Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.

21 January 2018

1 reference

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome

21 January 2018

1 reference

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

21 January 2018

1 reference

Nonoliguric acute renal failure associated with a low fractional excretion of sodium

21 January 2018

1 reference

Urinary interleukin-18 is a marker of human acute tubular necrosis

21 January 2018

1 reference

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.

21 January 2018

1 reference

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

21 January 2018

1 reference

Impact of pretransplant renal failure: when is listing for kidney-liver indicated?

21 January 2018

1 reference

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.

21 January 2018

1 reference

Simultaneous liver-kidney transplantation: evaluation to decision making.

21 January 2018

1 reference

Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations

21 January 2018

1 reference

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

21 January 2018

1 reference

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

21 January 2018

1 reference

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

21 January 2018

1 reference

Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome

21 January 2018

1 reference

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats

21 January 2018

1 reference

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

21 January 2018

1 reference

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

21 January 2018

1 reference

Vasoconstrictor therapy for the hepatorenal syndrome

21 January 2018

1 reference

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study

21 January 2018

1 reference

An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response

21 January 2018

1 reference

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

21 January 2018

1 reference

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

21 January 2018

1 reference

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

21 January 2018

1 reference

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

21 January 2018

1 reference

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

21 January 2018

1 reference

21 January 2018

The hepatorenal syndrome

1 reference

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

7 January 2021

Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score

1 reference

7 January 2021

Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.

1 reference

7 January 2021

Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure

1 reference

7 January 2021

Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation

1 reference

7 January 2021

Further evidence against the use of aminoglycosides in cirrhotic patients

1 reference

7 January 2021

Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study

1 reference

7 January 2021

Treatment of acute renal failure

1 reference

7 January 2021

Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy

1 reference

7 January 2021

Hepatorenal syndrome without avid sodium retention

1 reference

7 January 2021

Letter: Renal disorders in hepatic failure

1 reference

7 January 2021

Effects of renal impairment on liver transplantation

1 reference

7 January 2021

Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure

1 reference

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

7 January 2021

Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis

1 reference

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22605

1 reference

release_wehgpt36rffzhc6owr3zm3whte

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wehgpt36rffzhc6owr3zm3whte

24 November 2022

mapped directly with Wikidata item

1 reference